Stem Cell
•
A cell that has the ability to continuously divide and
differentiate (develop) into various other kind(s) of cells/tissues
Stages of Embryogenesis
Bone Marrow Stem Cells
Embryonic
|
Adult Stem Cells
|
▫
Totipotent
▫
Differentiation into ANY
cell type
▫
Known Source
▫
Large numbers can be harvested from embryos
▫
May cause immune rejection
▫
Rejection of ES cells by recipient has not been shown yet
|
•
Multi or pluripotent
▫
Differentiation into some cell types, limited outcomes
•
Unknown source
•
Limited numbers, more difficult to isolate
•
Less likely to cause immune rejection, since the patient’s own cells
can be used
|
History of Human Stem Cell Research
•
In 1968, the first bone marrow transplant was
successfully used in treatment of Severe combined immunodeficiency
•
Since the 1970’s, bone marrow transplants have been
used for treatment of immunodeficiencies and leukemias
History of Human Embryonic Cell Research
•
1954 – John Enders received a Nobel prize in Medicine
for growing polio virus in human embryonic kidney cells
History of Human Embryonic Stem Cell Research
In 1998, James Thomson (University of Wisconsin-Madison)
isolated cells from the inner cell mass of the early embryo, and developed the
first human embryonic stem cell lines.
•
1952 – Briggs and King cloned tadpoles
•
1996 – The first mammal cloned from adult cells was
Dolly, the sheep.
History of Cloning
Possible Uses of Stem Cell Technology
•
Replaceable tissues/organs
•
Repair of defective cell types
•
Delivery of genetic therapies
•
Delivery chemotherapeutic agents
Unknowns in Stem Cell/Cloning Research
•
It is uncertain that human embryonic stem cells in
vitro can give rise to all the different cell types of the adult body.
•
It is unknown if stem cells cultured in vitro
(apart from the embryo) will function as the cells do when they are part of the
developing embryo
Challenges to Stem Cell/Cloning Research
•
Stem cells need to be differentiated to the
appropriate cell type(s) before they can be used clinically.
•
Recently, abnormalities in chromosome number and
structure were found in three human ESC
lines.
•
Stem cell development or proliferation must be
controlled once placed into patients.
•
Possibility of rejection of stem cell transplants as
foreign tissues is very high.
•
Contamination by viruses, bacteria, fungi, and
Mycoplasma possible.
•
The use of mouse “feeder” cells to grow ESC could
result in problems due to xenotransplantation (complicating FDA requirements
for clinical use).
No comments:
Post a Comment